Vitamin K2 Market Outlook:
Vitamin K2 Market size was over USD 243.41 Million in 2025 and is poised to exceed USD 848.47 Million by 2035, growing at over 13.3% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of vitamin K2 is estimated at USD 272.55 Million.
The market's growth can be ascribed to the increasing number of patients suffering from vitamin K2 deficiency. This deficiency can lead to bleeding, osteoporosis, poor bone development and high risk of cardiovascular diseases. According to a report by the National Library of Medicine, vitamin K deficiency bleeding deficiency can occur in 0.25 to 1.7% of infants. Doctors often prescribe vitamin k2 supplements to pregnant women to avoid postpartum hemorrhage. According to the National Institutes of Health in 2023, out of 76.7 million delivery hospitalizations, 2.3 million were complicated by postpartum hemorrhage. The report further says that vitamin K supplementation for pregnant women provides remarkable benefits to both neonatal and maternal outcomes.
Besides this, vitamin K2 is a multifunctional micronutrient implicated in age-related diseases such as cardiovascular ailments and significant bleeding. According to data published by AARP in April 2021, about two-thirds of men over age 70 don’t get enough vitamin K2 in the U.S. Doctors are increasingly prescribing vitamin K2 to the old age population to keep bones healthy and prevent muscle weakness.
